Asia Pacific

As COVID-19 restrictions lift and society returns to face-to-face interaction, the regular seasonal sicknesses —colds and flus—are making their own return to Azerbaijan. More social mingling means not just handshakes and hugs on the rise; sniffling…

Even though cough, cold and allergy (hay fever) remedies recorded over 40% current value growth in 2022, it is anticipated that the category will continue to achieve high single-digit growth in 2023. Starting from late 2022, the end of the zero-COVID…

The removal of mask-wearing and social distancing measures in March 2023 led to rising demand for cough, cold and allergy remedies as respiratory infections increased. Since February 2020, local seasonal influenza in Hong Kong has remained at a low…

In 2023, cough, cold, and allergy (hay fever) remedies in India is set to experience moderate single-digit current value growth, driven predominantly by the demand for decongestants. Decongestants is expected to demonstrate above-average growth due…

Although the pandemic is considered over, this is not expected to immediately reduce sales of OTC cough and cold medicines in Indonesia in 2023, with both retail volume and current value growth set to continue across most categories. However, the…

Sales of cough, cold and allergy (hay fever) remedies in Japan have continued to recover in 2023. This is largely due to increased opportunities for consumers to go out and a shift away from the practice of wearing face masks on a daily basis. With…

Cough, cold and allergy (hay fever) remedies is experiencing a level of stabilisation in 2023. Following strong retail volume growth in the wake of the Coronavirus (COVID-19) pandemic, almost all categories are projected to see slower retail volume…

Cough, cold and allergy (hay fever) remedies witnessed an improved performance in constant value terms in 2023. This was due, in a large part, to a return of pre-pandemic lifestyles, including the reopening of schools and workspaces, which…

As people become more aware of the importance of self-care, there is a growing demand for OTC medications to treat cough and cold. Access to healthcare is limited and as such it is easier to buy OTC medications. Therefore, despite the increase in…

The pandemic brought about a huge increase in sales of cough, cold and allergy (hay fever) remedies, especially from the end of 2021, with later COVID-19 variants being revealed to have unique symptoms resembling those of the common cold. In February…

Like analgesics, sales of cough, cold and allergy (hay fever) remedies continue to rise, benefiting from the “tripledemic” of rising COVID-19 cases, the stronger return of influenza due to greater mobility outside of the home and contact with others,…

In line with rising health-consciousness, people in Taiwan are becoming more worried about the potentially hazardous side effects and contraindications of active pharmaceutical ingredients in standard OTC medications. This has continued to buoy…

In the Philippines, one interesting aspect of OTC products in general and cough, cold and allergy (hay fever) remedies in particular is that consumers are generally very aware of the active ingredients that are contained within these products and the…

Cough, cold and allergy (hay fever) remedies continued to enjoy healthy growth in current value terms in 2023. This was driven, to a large extent, by the revival of normal pre-pandemic patterns of behaviour, including the return of Thais to their…

Cough, cold and allergy remedies face favourable growth in 2023, with the category boosted by the return to normal social lifestyles post-pandemic. The regular circulation of seasonal cold viruses is fuelling demand, which had previously fallen due…

Vietnam has been experiencing a higher number of cases of influenza in 2023, which is benefiting sales of cough, cold and allergy (hay fever) remedies. Due to prolonged home seclusion as a result of pandemic-related restrictions, Vietnamese consumers…

The report will explore the key themes transforming consumer behaviour in Asia Pacific in the world beyond the pandemic, namely Digital Living, Rethink Wellness, Sustainable Living, Make My Life Easier and Search for Experiences, and the strategies…

Dermatologicals in Azerbaijan is recording an upward trajectory in 2023 but at a pace that could generously be called moderate, and notably slower in terms of volume sales compared to 2022. When it comes to dermatologicals, local consumer education…

In the wake of the pandemic, marked by an increased emphasis on holistic health, skin health has experienced a robust resurgence in 2023. Forecasts indicate that dermatologicals is poised to achieve steady mid-single-digit current value growth in…

Dermatologicals in Hong Kong saw continued positive growth in 2023. Steady growth in antifungals was driven by medicated shampoos, vaginal antifungals and other dermatologicals such as topical allergy remedies/antihistamines, with hair loss…